We are live on ! Find out more
EMR

Errol M. Rudman Portfolio holdings

AUM $148M Turnover 10%
1-Year Est. Return 19.65%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+19.65%
3 Year Est. Return
+60.53%
5 Year Est. Return
+120.34%
10 Year Est. Return
–
AUM
$199M
AUM Growth
+$43.7M
Cap. Flow
+$33.5M
Cap. Flow %
16.82%
Top 10 Hldgs %
59.34%
Holding
42
New
12
Increased
12
Reduced
6
Closed
–
Avg Time Held
1.5 years
Top 10 Avg Time Held
1.9 years
Top 20 Avg Time Held
2 years

Top Buys

Rank Stock Value
1
TDG icon
TransDigm Group
TDG
+$6.24M
2
IBB icon
iShares Biotechnology ETF
IBB
+$4.43M
3
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$4.26M
4
FND icon
Floor & Decor
FND
+$1.97M
5
MCK icon
McKesson
MCK
+$1.82M

Top Sells

Rank Stock Value
1
LVLT
Level 3 Communications Inc
LVLT
+$602K
2
TMO icon
Thermo Fisher Scientific
TMO
+$185K
3
CVS icon
CVS Health
CVS
+$130K
4
HCA icon
HCA Healthcare
HCA
+$118K
5
CBPO
China Biologic Products Holdings, Inc.
CBPO
+$83.8K

Sector Composition

Rank Sector Weight
1 Industrials 37.17%
2 Healthcare 23.07%
3 Consumer Discretionary 12.56%
4 Financials 8.6%
5 Miscellaneous 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
FND icon
26
Floor & Decor
FND
$4.87B
$1.98M 1%
+50,500
New +$1.97M
2017 Q2
0 quarters
THC icon
27
Tenet Healthcare
THC
$22.2B
$1.93M 0.97%
100,000
+50,000
+100% +$872K
2013 Q4
14 quarters
SEE icon
28
DELISTED
Sealed Air
SEE
$1.79M 0.9%
+40,000
New +$1.76M
2017 Q2
0 quarters
AAL icon
29
American Airlines Group
AAL
$8.13B
$1.7M 0.85%
33,720
+10,000
+42% +$465K
2017 Q1
1 quarter
ENTG icon
30
Entegris
ENTG
$22.4B
$1.7M 0.85%
77,291
– –
2017 Q1
1 quarter
TMO icon
31
Thermo Fisher Scientific
TMO
$258B
$1.45M 0.73%
8,300
-1,100
-12% -$185K
2013 Q4
14 quarters
ASML icon
32
ASML
ASML
$637B
$1.3M 0.65%
+10,000
New +$1.32M
2017 Q2
0 quarters
CGNX icon
33
Cognex
CGNX
$9.37B
$1.27M 0.64%
+30,000
New +$1.33M
2017 Q2
0 quarters
UGL icon
34
ProShares Ultra Gold
UGL
$728M
$1.19M 0.6%
126,000
+6,000
+5% +$58.4K
2017 Q1
1 quarter
C icon
35
Citigroup
C
$207B
$1M 0.5%
+15,000
New +$920K
2017 Q2
0 quarters
JPM icon
36
JPMorgan Chase
JPM
$891B
$914K 0.46%
+10,000
New +$863K
2017 Q2
0 quarters
WFC icon
37
Wells Fargo
WFC
$248B
$831K 0.42%
+15,000
New +$804K
2017 Q2
0 quarters
USFD icon
38
US Foods
USFD
$22B
$817K 0.41%
+30,000
New +$854K
2017 Q2
0 quarters
GE icon
39
GE Aerospace
GE
$324B
$650K 0.33%
5,018
– –
2016 Q4
2 quarters
LUMN icon
40
Lumen Technologies, Inc. Common Stock
LUMN
$5.02B
$478K 0.24%
+20,000
New +$502K
2017 Q2
0 quarters
CCRN icon
41
DELISTED
Cross Country Healthcare
CCRN
$443K 0.22%
34,282
-5,356
-14% -$69K
2014 Q2
12 quarters
BAC icon
42
Bank of America
BAC
$362B
$364K 0.18%
+15,000
New +$350K
2017 Q2
0 quarters
1
2

Similar funds

HAM
Hillswick Asset Management Stamford, Connecticut $150M AUM 7.89% 1-Year Est. Return
TAM
Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return
RMPT
Raytheon Master Pension Trust Waltham, Massachusetts $140M AUM 5.65% 1-Year Est. Return
QAM
Quantres Asset Management Cayman, Cayman Islands $138M AUM 11.79% 1-Year Est. Return
CWM
Catamount Wealth Management Westport, Connecticut $176M AUM 15.01% 1-Year Est. Return
RCA
Restructuring Capital Associates Stamford, Connecticut $115M AUM 20.18% 1-Year Est. Return
CI
Caerus Investors New York $183M AUM 0.18% 1-Year Est. Return
LS
Lattice Strategies Wayne, Pennsylvania $109M AUM 3.52% 1-Year Est. Return

Errol M. Rudman's Q2 2017 Portfolio in Review

As of Q2 2017, Errol M. Rudman held 42 positions worth $199M, up 28% from $155M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Errol M. Rudman deployed $33.5M of net new capital in Q2 2017, opening 12 new positions and adding to 12 existing holdings. Its largest new stake was iShares Biotechnology ETF: 45,000 shares worth $4.65M.

By sector, the portfolio is most concentrated in Industrials at 37% of assets, down from 39% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Level 3 Communications Inc, an estimated $602K trimmed.

  • Errol M. Rudman's largest Q2 2017 buy was iShares Biotechnology ETF: 45,000 shares worth $4.65M.
  • Errol M. Rudman added most to TransDigm Group in Q2 2017, an estimated $6.24M increase.
  • Errol M. Rudman's biggest Q2 2017 reduction was Level 3 Communications Inc, cutting an estimated $602K.
  • Errol M. Rudman's ten largest holdings make up 59% of its $199M portfolio in Q2 2017.
  • Errol M. Rudman opened 12 new positions and closed 0 in Q2 2017.
  • Errol M. Rudman's portfolio value rose 28% quarter-over-quarter to $199M.

Based on Errol M. Rudman's 13F filing for Q2 2017, filed 14 Aug 2017.